224 related articles for article (PubMed ID: 21248110)
1. The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
Ramerstorfer J; Furtmüller R; Sarto-Jackson I; Varagic Z; Sieghart W; Ernst M
J Neurosci; 2011 Jan; 31(3):870-7. PubMed ID: 21248110
[TBL] [Abstract][Full Text] [Related]
2. Molecular mode of action of CGS 9895 at α1 β2 γ2 GABAA receptors.
Maldifassi MC; Baur R; Sigel E
J Neurochem; 2016 Sep; 138(5):722-30. PubMed ID: 27319298
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852
[TBL] [Abstract][Full Text] [Related]
4. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935
[TBL] [Abstract][Full Text] [Related]
5. Unexpected Properties of δ-Containing GABAA Receptors in Response to Ligands Interacting with the α+ β- Site.
Mirheydari P; Ramerstorfer J; Varagic Z; Scholze P; Wimmer L; Mihovilovic MM; Sieghart W; Ernst M
Neurochem Res; 2014 Jun; 39(6):1057-1067. PubMed ID: 24072672
[TBL] [Abstract][Full Text] [Related]
6. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.
Feng HJ; Jounaidi Y; Haburcak M; Yang X; Forman SA
Br J Pharmacol; 2014 Feb; 171(3):789-98. PubMed ID: 24199598
[TBL] [Abstract][Full Text] [Related]
7. Comparison of αβδ and αβγ GABA
Feng HJ; Forman SA
Pharmacol Res; 2018 Jul; 133():289-300. PubMed ID: 29294355
[TBL] [Abstract][Full Text] [Related]
8. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
10. Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces.
Sharkey LM; Czajkowski C
Mol Pharmacol; 2008 Jul; 74(1):203-12. PubMed ID: 18424553
[TBL] [Abstract][Full Text] [Related]
11. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.
Che Has AT; Absalom N; van Nieuwenhuijzen PS; Clarkson AN; Ahring PK; Chebib M
Sci Rep; 2016 Jun; 6():28674. PubMed ID: 27346730
[TBL] [Abstract][Full Text] [Related]
12. Alcohol selectivity of β3-containing GABAA receptors: evidence for a unique extracellular alcohol/imidazobenzodiazepine Ro15-4513 binding site at the α+β- subunit interface in αβ3δ GABAA receptors.
Wallner M; Hanchar HJ; Olsen RW
Neurochem Res; 2014 Jun; 39(6):1118-26. PubMed ID: 24500446
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of GABAA receptors containing gamma1 subunits.
Khom S; Baburin I; Timin EN; Hohaus A; Sieghart W; Hering S
Mol Pharmacol; 2006 Feb; 69(2):640-9. PubMed ID: 16272224
[TBL] [Abstract][Full Text] [Related]
14. Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site.
Middendorp SJ; Maldifassi MC; Baur R; Sigel E
Neuropharmacology; 2015 Aug; 95():459-67. PubMed ID: 25963418
[TBL] [Abstract][Full Text] [Related]
15. Engineered Flumazenil Recognition Site Provides Mechanistic Insight Governing Benzodiazepine Modulation in GABA
Siebert DCB; Bampali K; Puthenkalam R; Varagic Z; Sarto-Jackson I; Scholze P; Sieghart W; Mihovilovic MD; Schnürch M; Ernst M
ACS Chem Biol; 2018 Aug; 13(8):2040-2047. PubMed ID: 29989390
[TBL] [Abstract][Full Text] [Related]
16. Proton modulation of alpha 1 beta 3 delta GABAA receptor channel gating and desensitization.
Feng HJ; Macdonald RL
J Neurophysiol; 2004 Sep; 92(3):1577-85. PubMed ID: 15152020
[TBL] [Abstract][Full Text] [Related]
17. A role for loop G in the β1 strand in GABAA receptor activation.
Baptista-Hon DT; Krah A; Zachariae U; Hales TG
J Physiol; 2016 Oct; 594(19):5555-71. PubMed ID: 27195487
[TBL] [Abstract][Full Text] [Related]
18. Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptors.
Hall BJ; Chebib M; Hanrahan JR; Johnston GA
Eur J Pharmacol; 2004 Apr; 491(1):1-8. PubMed ID: 15102527
[TBL] [Abstract][Full Text] [Related]
19. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
[TBL] [Abstract][Full Text] [Related]
20. GABA
Has ATC; Chebib M
Curr Pharm Des; 2018; 24(17):1839-1844. PubMed ID: 29766792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
